Cryo-Cell International Stock (AMEX: CCEL) stock price, news, charts, stock research, profile.
Open | $7.930 |
Close | - |
Volume / Avg. | 17.545K / 10.716K |
Day Range | 7.909 - 8.150 |
52 Wk Range | 3.670 - 8.150 |
Market Cap | $69.613M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 69 |
Short Interest | 0.41% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cryo-Cell International (AMEX: CCEL) through any online brokerage.
Other companies in Cryo-Cell International’s space includes: Aveanna Healthcare Hldgs (NASDAQ:AVAH), GeneDx Hldgs (NASDAQ:WGS), Prenetics Global (NASDAQ:PRE), ATI Physical Therapy (NYSE:ATIP) and Talkspace (NASDAQ:TALK).
The latest price target for Cryo-Cell International (AMEX: CCEL) was reported by Maxim Group on Monday, August 29, 2022. The analyst firm set a price target for 12.00 expecting CCEL to rise to within 12 months (a possible 39.71% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Cryo-Cell International (AMEX: CCEL) is $8.5894 last updated Today at April 26, 2024 at 12:50 PM EDT.
A quarterly cash dividend of $0.01 per share of Class A Common Stock. The quarterly cash dividend was payable on Invalid DateTime to stockholders of record on August 29, 2001.
Cryo-Cell International’s Q2 earnings are confirmed for Friday, July 12, 2024.
There is no upcoming split for Cryo-Cell International.
Cryo-Cell International is in the Health Care sector and Health Care Providers & Services industry. They are listed on the AMEX.